Role of dendritic cells in SARS coronavirus infection.

1. Severe acute respiratory syndrome coronavirus (SARSCoV) entered and replicated in monocyte-derived dendritic cells (DCs), but virus replication was incomplete. In addition, SARS-CoV did not induce apoptosis or maturation of infected DCs. 2. SARS-CoV infected DCs showed low expression of antiviral cytokines (IFN-α, IFN-β, IFN-γ, and IL-12p40), moderate up-regulation of proinflammatory cytokines (TNF-α and IL-6), and significant up-regulation of inflammatory chemokines (MIP-1α, RANTES, IP-10, and MCP-1). 3. SARS-CoV did not modulate gene expression of Toll-like receptors (TLR-1 to 10) but induced significant up-regulation of chemokine receptors (CCR1, CCR-3, CCR-5). 4. SARS-CoV induced high expression of TRAIL but not FasL gene expression in DCs. 5. The characteristic phenotype of SARS-CoV infected DCs suggested some possible mechanisms of immune escape and amplification of immunopathology in SARS.

[1]  Y. Lau,et al.  Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells , 2009, BMC Immunology.

[2]  M. McNutt,et al.  Pathogenetic mechanisms of severe acute respiratory syndrome , 2007, Virus Research.

[3]  Ralph Baric,et al.  SARS coronavirus and innate immunity , 2007, Virus Research.

[4]  John P. Moore,et al.  HIV-1 pathogenesis: the complexities of the CCR5-CCL3L1 complex. , 2007, Cell host & microbe.

[5]  D. Graham,et al.  HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-α , 2007, Proceedings of the National Academy of Sciences.

[6]  H. Ueno,et al.  Dendritic cell subsets in health and disease , 2007, Immunological reviews.

[7]  R. Baric,et al.  Severe Acute Respiratory Syndrome Coronavirus Evades Antiviral Signaling: Role of nsp1 and Rational Design of an Attenuated Strain , 2007, Journal of Virology.

[8]  T. Kopp,et al.  Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells , 2007, The Journal of experimental medicine.

[9]  R. Förster,et al.  A key role for CCR7 in establishing central and peripheral tolerance. , 2007, Trends in immunology.

[10]  Man Wai Ng,et al.  The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese , 2007, BMC infectious diseases.

[11]  K. Subbarao,et al.  The Immunobiology of SARS*. , 2007, Annual review of immunology.

[12]  Tracy M Handel,et al.  Chemokine: receptor structure, interactions, and antagonism. , 2007, Annual review of immunology.

[13]  L. Parker,et al.  Translational Mini‐Review Series on Toll‐like Receptors:
Networks regulated by Toll‐like receptors mediate innate and adaptive immunity , 2007, Clinical and experimental immunology.

[14]  J. Peiris,et al.  SARS-coronavirus induced different gene expression of chemokine receptors in human monocyte-derived adult and cord blood dendritic cells , 2007 .

[15]  P. Palese,et al.  Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists , 2006, Journal of Virology.

[16]  J. Peiris,et al.  Functional Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Production by Avian Influenza Virus–Infected Macrophages , 2006, The Journal of infectious diseases.

[17]  Y. Lau,et al.  Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells , 2005, Blood.

[18]  S. Paludan,et al.  Age-Dependent Role for CCR5 in Antiviral Host Defense against Herpes Simplex Virus Type 2 , 2005, Journal of Virology.

[19]  Y. Lau,et al.  Pathogenesis of severe acute respiratory syndrome , 2005, Current Opinion in Immunology.

[20]  M. Zenke,et al.  Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migration. , 2005, The Journal of general virology.

[21]  Jun Xu,et al.  Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. , 2005, American journal of respiratory and critical care medicine.

[22]  H. Smits,et al.  Different faces of regulatory DCs in homeostasis and immunity. , 2005, Trends in immunology.

[23]  Michelle M. Packard,et al.  Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan , 2005, Human Pathology.

[24]  Y. Lau SARS: future research and vaccine , 2004, Paediatric Respiratory Reviews.

[25]  M. Netea,et al.  Toll-like receptors as an escape mechanism from the host defense. , 2004, Trends in microbiology.

[26]  B. Murphy,et al.  Mechanisms of Host Defense following Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) Pulmonary Infection of Mice , 2004, The Journal of Immunology.

[27]  R. Schleimer,et al.  Activation of airway epithelial cells by toll-like receptor agonists. , 2004, American journal of respiratory cell and molecular biology.

[28]  Jing Li,et al.  Analysis of Serum Cytokines in Patients with Severe Acute Respiratory Syndrome , 2004, Infection and Immunity.

[29]  P. Vidalain,et al.  HIV type 1-infected dendritic cells induce apoptotic death in infected and uninfected primary CD4 T lymphocytes. , 2004, AIDS research and human retroviruses.

[30]  N. Bhardwaj,et al.  DC-virus interplay: a double edged sword. , 2004, Seminars in immunology.

[31]  J. Peiris,et al.  Severe acute respiratory syndrome among children. , 2004, Pediatrics.

[32]  K. Subbarao,et al.  pH-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus Is Mediated by the Spike Glycoprotein and Enhanced by Dendritic Cell Transfer through DC-SIGN , 2004, Journal of Virology.

[33]  M. Netea,et al.  Toll‐like receptors and the host defense against microbial pathogens: bringing specificity to the innate‐immune system , 2004, Journal of leukocyte biology.

[34]  T. Giese,et al.  Frontline: Induction of apoptosis and modulation of c‐FLIPL and p53 in immature dendritic cells infected with herpes simplex virus , 2004, European journal of immunology.

[35]  Hervé Groux,et al.  Role of dendritic cells in the generation of regulatory T cells. , 2004, Seminars in immunology.

[36]  J. Sung,et al.  Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome , 2004, Clinical and experimental immunology.

[37]  U. V. von Andrian,et al.  Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. , 2004, Annual review of immunology.

[38]  P. Allavena,et al.  Chemokines and Dendritic Cell Traffic , 2000, Journal of Clinical Immunology.

[39]  J. Banchereau,et al.  Dendritic Cells: A Link Between Innate and Adaptive Immunity , 2004, Journal of Clinical Immunology.

[40]  M. Chan-yeung,et al.  High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. , 2003, American journal of respiratory and critical care medicine.

[41]  H. Rosenberg,et al.  Chemokine regulation of inflammation during acute viral infection , 2003, Current opinion in allergy and clinical immunology.

[42]  O. Tsang,et al.  Outcomes and Prognostic Factors in 267 Patients with Severe Acute Respiratory Syndrome in Hong Kong , 2003, Annals of Internal Medicine.

[43]  M. Goldman,et al.  Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. , 2003, Journal of autoimmunity.

[44]  J. O’Shea,et al.  The biology of IL-12: coordinating innate and adaptive immune responses. , 2003, Cytokine & growth factor reviews.

[45]  K. Lamberth,et al.  CCR3 Expression Induced by IL-2 and IL-4 Functioning as a Death Receptor for B Cells1 , 2003, The Journal of Immunology.

[46]  Xin Li,et al.  The clinical pathology of severe acute respiratory syndrome (SARS): a report from China , 2003, The Journal of pathology.

[47]  J. Sung,et al.  Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis , 2003, BMJ : British Medical Journal.

[48]  Ruslan Medzhitov,et al.  Toll-Like Receptor Signaling Pathways , 2003, Science.

[49]  L. Poon,et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .

[50]  Yi Guan,et al.  Lung pathology of fatal severe acute respiratory syndrome , 2003, The Lancet.

[51]  Christian Drosten,et al.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[52]  Katsuaki Sato,et al.  Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. , 2003, Blood.

[53]  Y. Guan,et al.  Coronavirus as a possible cause of severe acute respiratory syndrome , 2003, The Lancet.

[54]  R. Steinman,et al.  DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells , 2003, The Journal of experimental medicine.

[55]  K. Legge,et al.  Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. , 2003, Immunity.

[56]  D. Levy,et al.  Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity. , 2003, Current opinion in immunology.

[57]  C. Benedict,et al.  Death and survival: viral regulation of TNF signaling pathways. , 2003, Current opinion in immunology.

[58]  V. ter meulen,et al.  Dendritic cells and measles virus infection. , 2003, Current topics in microbiology and immunology.

[59]  Y. Guan,et al.  Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.

[60]  T. Geijtenbeek,et al.  Immune escape through C-type lectins on dendritic cells. , 2002, Trends in immunology.

[61]  R. Steinman,et al.  Expression of a Functional Eotaxin (CC Chemokine Ligand 11) Receptor CCR3 by Human Dendritic Cells1 2 3 , 2002, The Journal of Immunology.

[62]  R. Steinman,et al.  Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. , 2002, Blood.

[63]  T. Geijtenbeek,et al.  DC‐SIGN, a C‐type lectin on dendritic cells that unveils many aspects of dendritic cell biology , 2002, Journal of leukocyte biology.

[64]  R. Medzhitov,et al.  Toll-like receptors and their ligands. , 2002, Current topics in microbiology and immunology.

[65]  Mary F Lipscomb,et al.  Dendritic cells: immune regulators in health and disease. , 2002, Physiological reviews.

[66]  M. Raftery,et al.  Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. , 2001, Immunity.

[67]  N. Kadowaki,et al.  Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens , 2001, The Journal of experimental medicine.

[68]  S. Akira,et al.  Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.

[69]  B. Graham,et al.  Viruses, dendritic cells and the lung , 2001, Respiratory research.

[70]  F. Belardelli,et al.  Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. , 2001, Immunity.

[71]  R. Locksley,et al.  The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.

[72]  Nina Bhardwaj,et al.  Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[73]  S. Dower,et al.  Regulation of Toll-Like Receptors in Human Monocytes and Dendritic Cells1 , 2001, The Journal of Immunology.

[74]  D. Gemsa,et al.  Defense against influenza A virus infection: essential role of the chemokine system. , 2001, Immunobiology.

[75]  G. Sen,et al.  Viruses and interferons. , 2001, Annual review of microbiology.

[76]  F. Sallusto,et al.  Understanding dendritic cell and T‐lymphocyte traffic through the analysis of chemokine receptor expression , 2000, Immunological reviews.

[77]  P. Vidalain,et al.  Measles Virus Induces Functional TRAIL Production by Human Dendritic Cells , 2000, Journal of Virology.

[78]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[79]  C. Caux,et al.  Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines , 1999, Journal of leukocyte biology.

[80]  Hanno Langen,et al.  Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA , 1999, The Journal of experimental medicine.

[81]  Y. Yamaguchi,et al.  EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. , 1998, Journal of immunology.

[82]  M. Gobbi,et al.  Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. , 1997, Journal of immunology.

[83]  W I Wood,et al.  Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. , 1997, Science.

[84]  A. Sica,et al.  MCP‐1 and CCR2 in HIV infection: regulation of agonist and receptor expression , 1997, Journal of leukocyte biology.

[85]  R. Rueckert Picornaviridae: The viruses and their replication , 1996 .